Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Vida Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Vida Ventures

Vida Ventures

Operating

Vida Ventures Advisors LLC: A bicoastal venture capital firm investing in life sciences, healthcare, and biotech.

Location
Boston, MA, US
Founded
2019
Firm
Compare
Portfolio
Employees
Website

Vida Ventures is a bicoastal venture capital firm focused on investing in life sciences, healthcare, and biotechnology companies. The firm primarily targets early to mid-stage investments, with a strong emphasis on Series A and B rounds. Vida Ventures aims to transform biomedical innovations into therapies that make a meaningful difference in patients' lives.

The firm's portfolio includes notable companies such as Allogene Therapeutics, Kronos Bio, and Kyverna Therapeutics. Vida Ventures offers value-add services to its portfolio companies, leveraging its expertise in the biomedical field to support the development of innovative therapies. The firm's investment philosophy centers on identifying and nurturing groundbreaking scientific advancements with the potential to address significant unmet medical needs.

Vida Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments36
Current Portfolio Count20
Total Portfolio Exits2

Top Investment Stages

Series A15 (45.5%)
Series B9 (27.3%)
Seed4 (12.1%)
Series C3 (9.1%)
Series E2 (6.1%)

Stage Mix

Series A 45%Series B 27%Seed 12%Series C 9%Series E 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SonoThera logo

SonoThera

Avalyn Pharma logo

Avalyn Pharma

ReCode Therapeutics logo

ReCode Therapeutics

Kyverna Therapeutics logo

Kyverna Therapeutics

Quanta Therapeutics logo

Quanta Therapeutics

Volastra Therapeutics logo

Volastra Therapeutics

Alterome Therapeutics logo

Alterome Therapeutics

Capstan Therapeutics logo

Capstan Therapeutics

Aktis Oncology logo

Aktis Oncology

Affini-T Therapeutics logo

Affini-T Therapeutics

Protego Biopharma logo

Protego Biopharma

Tectonic Therapeutic logo

Tectonic Therapeutic

Scorpion Therapeutics logo

Scorpion Therapeutics

IconOVir Bio logo

IconOVir Bio

Locanabio logo

Locanabio

A2 Biotherapeutics logo

A2 Biotherapeutics

Kronos Bio logo

Kronos Bio

Pact Pharma logo

Pact Pharma

Peloton Therapeutics logo

Peloton Therapeutics

Sutro Biopharma logo

Sutro Biopharma

Allogene Therapeutics logo

Allogene Therapeutics

Pionyr Immunotherapeutics logo

Pionyr Immunotherapeutics

Vida Ventures - Similar Investment Firms

Bioventures Investors logo

Bioventures Investors

Versant Ventures logo

Versant Ventures

Third Rock Ventures logo

Third Rock Ventures

Atlas Venture logo

Atlas Venture

atlasventure.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Valia Ventures logo

Valia Ventures

valia.vc

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

Biovision Ventures logo

Biovision Ventures

biovision.vc

30Ventures logo

30Ventures

5AM Ventures logo

5AM Ventures

5amventures.com

Avoro Capital Advisors logo

Avoro Capital Advisors

avorocapital.com

V-Bio Ventures logo

V-Bio Ventures

v-bio.ventures

Vine Ventures logo

Vine Ventures

vineventures.com

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Vida Ventures - Classification

Also Known As
  • Vida Ventures Advisors, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end